Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Interoperable and scalable data analysis with microservices: Applications in Metabolomics.

Emami Khoonsari P, Moreno P, Bergmann S, Burman J, Capuccini M, Carone M, Cascante M, de Atauri P, Foguet C, Gonzalez-Beltran A, Hankemeier T, Haug K, He S, Herman S, Johnson D, Kale N, Larsson A, Neumann S, Peters K, Pireddu L, Rocca-Serra P, Roger P, Rueedi R, Ruttkies C, Sadawi N, Salek RM, Sansone SA, Schober D, Selivanov V, Thévenot EA, van Vliet M, Zanetti G, Steinbeck C, Kultima K, Spjuth O.

Bioinformatics. 2019 Mar 9. pii: btz160. doi: 10.1093/bioinformatics/btz160. [Epub ahead of print]

PMID:
30851093
2.

Capillary Electrophoresis-Mass Spectrometry for Metabolic Profiling of Biomass-Limited Samples.

Zhang W, Hankemeier T, Ramautar R.

Methods Mol Biol. 2019;1972:165-172. doi: 10.1007/978-1-4939-9213-3_11.

PMID:
30847790
3.

The influence of neuronal electrical activity on the mammalian central clock metabolome.

Buijink MR, van Weeghel M, Gülersönmez MC, Harms AC, Rohling JHT, Meijer JH, Hankemeier T, Michel S.

Metabolomics. 2018 Sep 17;14(10):122. doi: 10.1007/s11306-018-1423-z.

4.

Global testing of shifts in metabolic phenotype.

Fazelzadeh P, Hoefsloot HCJ, Hankemeier T, Most J, Kersten S, Blaak EE, Boekschoten M, van Duynhoven J.

Metabolomics. 2018 Oct 4;14(10):139. doi: 10.1007/s11306-018-1435-8.

5.

Impact of post-hatching maturation on the pharmacokinetics of paracetamol in zebrafish larvae.

van Wijk RC, Krekels EHJ, Kantae V, Harms AC, Hankemeier T, van der Graaf PH, Spaink HP.

Sci Rep. 2019 Feb 15;9(1):2149. doi: 10.1038/s41598-019-38530-w.

6.

Automated microfluidic cell culture of stem cell derived dopaminergic neurons.

Kane KIW, Moreno EL, Hachi S, Walter M, Jarazo J, Oliveira MAP, Hankemeier T, Vulto P, Schwamborn JC, Thoma M, Fleming RMT.

Sci Rep. 2019 Feb 11;9(1):1796. doi: 10.1038/s41598-018-34828-3.

7.

Discovery of novel glycerolated quinazolinones from Streptomyces sp. MBT27.

Machushynets NV, Wu C, Elsayed SS, Hankemeier T, van Wezel GP.

J Ind Microbiol Biotechnol. 2019 Mar;46(3-4):483-492. doi: 10.1007/s10295-019-02140-2. Epub 2019 Feb 7.

PMID:
30729343
8.

High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue.

Kuipers EN, Kantae V, Maarse BCE, van den Berg SM, van Eenige R, Nahon KJ, Reifel-Miller A, Coskun T, de Winther MPJ, Lutgens E, Kooijman S, Harms AC, Hankemeier T, van der Stelt M, Rensen PCN, Boon MR.

Front Physiol. 2019 Jan 10;9:1913. doi: 10.3389/fphys.2018.01913. eCollection 2018.

9.

Blood-Based Biomarkers of Quinpirole Pharmacology: Cluster-Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and Brain.

van den Brink WJ, Hartman R, van den Berg DJ, Flik G, Gonzalez-Amoros B, Koopman N, Elassais-Schaap J, van der Graaf PH, Hankemeier T, de Lange ECM.

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):107-117. doi: 10.1002/psp4.12370. Epub 2019 Jan 24.

10.

Activity-Based Protein Profiling Identifies α-Ketoamides as Inhibitors for Phospholipase A2 Group XVI.

Zhou J, Mock ED, Martella A, Kantae V, Di X, Burggraaff L, Baggelaar MP, Al-Ayed K, Bakker A, Florea BI, Grimm SH, den Dulk H, Li CT, Mulder L, Overkleeft HS, Hankemeier T, van Westen GJP, van der Stelt M.

ACS Chem Biol. 2019 Feb 15;14(2):164-169. doi: 10.1021/acschembio.8b00969. Epub 2019 Jan 18.

11.

Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools.

Goulooze SC, Krekels EHJ, Hankemeier T, Knibbe CAJ.

AAPS J. 2018 Dec 18;21(1):11. doi: 10.1208/s12248-018-0278-6.

PMID:
30565031
12.

Utility of sheathless capillary electrophoresis-mass spectrometry for metabolic profiling of limited sample amounts.

Zhang W, Guled F, Hankemeier T, Ramautar R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 15;1105:10-14. doi: 10.1016/j.jchromb.2018.12.004. Epub 2018 Dec 6.

13.

PhenoMeNal: processing and analysis of metabolomics data in the cloud.

Peters K, Bradbury J, Bergmann S, Capuccini M, Cascante M, de Atauri P, Ebbels TMD, Foguet C, Glen R, Gonzalez-Beltran A, Günther UL, Handakas E, Hankemeier T, Haug K, Herman S, Holub P, Izzo M, Jacob D, Johnson D, Jourdan F, Kale N, Karaman I, Khalili B, Emami Khonsari P, Kultima K, Lampa S, Larsson A, Ludwig C, Moreno P, Neumann S, Novella JA, O'Donovan C, Pearce JTM, Peluso A, Piras ME, Pireddu L, Reed MAC, Rocca-Serra P, Roger P, Rosato A, Rueedi R, Ruttkies C, Sadawi N, Salek RM, Sansone SA, Selivanov V, Spjuth O, Schober D, Thévenot EA, Tomasoni M, van Rijswijk M, van Vliet M, Viant MR, Weber RJM, Zanetti G, Steinbeck C.

Gigascience. 2019 Feb 1;8(2). pii: giy149. doi: 10.1093/gigascience/giy149.

14.

Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.

Peltenburg NC, Schoeman JC, Hou J, Mora F, Harms AC, Lowe SH, Bierau J, Bakker JA, Verbon A, Hankemeier T, Boonstra A.

Sci Rep. 2018 Nov 16;8(1):16947. doi: 10.1038/s41598-018-35271-0.

15.

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.

Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Jia W, Xie G, Ahmad S, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2019 Feb;15(2):232-244. doi: 10.1016/j.jalz.2018.08.012. Epub 2018 Oct 15.

PMID:
30337152
16.

Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.

MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, St John Williams L, Tenenbaum JD, Blach C, Baillie R, Han X, Bhattacharyya S, Toledo JB, Schafferer S, Klein S, Koal T, Risacher SL, Kling MA, Motsinger-Reif A, Rotroff DM, Jack J, Hankemeier T, Bennett DA, De Jager PL, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn CM, Saykin AJ, Kastenmüller G, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2019 Jan;15(1):76-92. doi: 10.1016/j.jalz.2018.07.217. Epub 2018 Oct 15. Erratum in: Alzheimers Dement. 2019 Mar 21;:.

17.

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.

Teitsma XM, Yang W, Jacobs JWG, Pethö-Schramm A, Borm MEA, Harms AC, Hankemeier T, van Laar JM, Bijlsma JWJ, Lafeber FPJG.

Arthritis Res Ther. 2018 Oct 15;20(1):230. doi: 10.1186/s13075-018-1729-2.

18.

Menstrual cycle rhythmicity: metabolic patterns in healthy women.

Draper CF, Duisters K, Weger B, Chakrabarti A, Harms AC, Brennan L, Hankemeier T, Goulet L, Konz T, Martin FP, Moco S, van der Greef J.

Sci Rep. 2018 Oct 1;8(1):14568. doi: 10.1038/s41598-018-32647-0.

19.

Plasma lipid profiling of tissue-specific insulin resistance in human obesity.

van der Kolk BW, Vogelzangs N, Jocken JWE, Valsesia A, Hankemeier T, Astrup A, Saris WHM, Arts ICW, van Greevenbroek MMJ, Blaak EE; DiOGenes consortium.

Int J Obes (Lond). 2018 Sep 21. doi: 10.1038/s41366-018-0189-8. [Epub ahead of print]

PMID:
30242234
20.

Perfused 3D angiogenic sprouting in a high-throughput in vitro platform.

van Duinen V, Zhu D, Ramakers C, van Zonneveld AJ, Vulto P, Hankemeier T.

Angiogenesis. 2019 Feb;22(1):157-165. doi: 10.1007/s10456-018-9647-0. Epub 2018 Aug 31.

PMID:
30171498
21.

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate.

Kaddurah-Daouk R, Hankemeier T, Scholl EH, Baillie R, Harms A, Stage C, Dalhoff KP, Jűrgens G, Taboureau O, Nzabonimpa GS, Motsinger-Reif AA, Thomsen R, Linnet K, Rasmussen HB; INDICES Consortium; Pharmacometabolomics Research Network.

CPT Pharmacometrics Syst Pharmacol. 2018 Aug;7(8):525-533. doi: 10.1002/psp4.12309.

22.

Gene Expression of Endocannabinoid System Components in Skeletal Muscle and Adipose Tissue of South Asians and White Caucasians with Overweight.

Nahon KJ, Kantae V, den Haan R, Hanssen MJW, Harms AC, van der Stelt M, Hankemeier T, Jazet IM, van Marken Lichtenbelt WD, Rensen PCN, Boon MR.

Obesity (Silver Spring). 2018 Aug;26(8):1332-1337. doi: 10.1002/oby.22245. Epub 2018 Aug 1.

PMID:
30070030
23.

High-Resolution Analysis of the Peptidoglycan Composition in Streptomyces coelicolor.

van der Aart LT, Spijksma GK, Harms A, Vollmer W, Hankemeier T, van Wezel GP.

J Bacteriol. 2018 Sep 24;200(20). pii: e00290-18. doi: 10.1128/JB.00290-18. Print 2018 Oct 15.

24.

Fusing metabolomics data sets with heterogeneous measurement errors.

Waaijenborg S, Korobko O, Willems van Dijk K, Lips M, Hankemeier T, Wilderjans TF, Smilde AK, Westerhuis JA.

PLoS One. 2018 Apr 26;13(4):e0195939. doi: 10.1371/journal.pone.0195939. eCollection 2018.

25.

Mass spectrometric recommendations for Quan/Qual analysis using liquid-chromatography coupled to quadrupole time-of-flight mass spectrometry.

Dubbelman AC, Cuyckens F, Dillen L, Gross G, Vreeken RJ, Hankemeier T.

Anal Chim Acta. 2018 Aug 22;1020:62-75. doi: 10.1016/j.aca.2018.02.055. Epub 2018 Mar 3.

26.

Weight loss moderately affects the mixed meal challenge response of the plasma metabolome and transcriptome of peripheral blood mononuclear cells in abdominally obese subjects.

Fazelzadeh P, Hangelbroek RWJ, Joris PJ, Schalkwijk CG, Esser D, Afman L, Hankemeier T, Jacobs DM, Mihaleva VV, Kersten S, van Duynhoven J, Boekschoten MV.

Metabolomics. 2018;14(4):46. doi: 10.1007/s11306-018-1328-x. Epub 2018 Mar 5.

27.

Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling.

Noga MJ, Zielman R, van Dongen RM, Bos S, Harms A, Terwindt GM, van den Maagdenberg AMJM, Hankemeier T, Ferrari MD.

Metabolomics. 2018;14(4):44. doi: 10.1007/s11306-018-1333-0. Epub 2018 Mar 5.

28.

Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics.

van den Brink WJ, Hankemeier T, van der Graaf PH, de Lange ECM.

Expert Opin Drug Discov. 2018 Jun;13(6):539-550. doi: 10.1080/17460441.2018.1446935. Epub 2018 Mar 8. Review.

PMID:
29519169
29.

Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress.

Schoeman JC, Harms AC, van Weeghel M, Berger R, Vreeken RJ, Hankemeier T.

Anal Bioanal Chem. 2018 Apr;410(10):2551-2568. doi: 10.1007/s00216-018-0912-2. Epub 2018 Mar 2.

30.

A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach.

Fu J, Chang L, Harms AC, Jia Z, Wang H, Wei C, Qiao L, Tian S, Hankemeier T, Wu Y, Wang M.

Sci Rep. 2018 Feb 27;8(1):3688. doi: 10.1038/s41598-018-22074-6.

31.

Pharmacological targeting of ROS reaction network in myeloid leukemia cells monitored by ultra-weak photon emission.

Rossetto Burgos RC, Ramautar R, Van Wijk EPA, Hankemeier T, Der Greef JV, Mashaghi A.

Oncotarget. 2017 Dec 11;9(2):2028-2034. doi: 10.18632/oncotarget.23175. eCollection 2018 Jan 5.

32.

Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.

van Eyk HJ, van Schinkel LD, Kantae V, Dronkers CEA, Westenberg JJM, de Roos A, Lamb HJ, Jukema JW, Harms AC, Hankemeier T, van der Stelt M, Jazet IM, Rensen PCN, Smit JWA.

Nutr Diabetes. 2018 Jan 17;8(1):6. doi: 10.1038/s41387-017-0016-7.

33.

Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies.

van der Lee SJ, Teunissen CE, Pool R, Shipley MJ, Teumer A, Chouraki V, Melo van Lent D, Tynkkynen J, Fischer K, Hernesniemi J, Haller T, Singh-Manoux A, Verhoeven A, Willemsen G, de Leeuw FA, Wagner H, van Dongen J, Hertel J, Budde K, Willems van Dijk K, Weinhold L, Ikram MA, Pietzner M, Perola M, Wagner M, Friedrich N, Slagboom PE, Scheltens P, Yang Q, Gertzen RE, Egert S, Li S, Hankemeier T, van Beijsterveldt CEM, Vasan RS, Maier W, Peeters CFW, Jörgen Grabe H, Ramirez A, Seshadri S, Metspalu A, Kivimäki M, Salomaa V, Demirkan A, Boomsma DI, van der Flier WM, Amin N, van Duijn CM.

Alzheimers Dement. 2018 Jun;14(6):707-722. doi: 10.1016/j.jalz.2017.11.012. Epub 2018 Jan 6. Erratum in: Alzheimers Dement. 2019 Feb;15(2):319.

34.

96 perfusable blood vessels to study vascular permeability in vitro.

van Duinen V, van den Heuvel A, Trietsch SJ, Lanz HL, van Gils JM, van Zonneveld AJ, Vulto P, Hankemeier T.

Sci Rep. 2017 Dec 22;7(1):18071. doi: 10.1038/s41598-017-14716-y.

35.

The future of metabolomics in ELIXIR.

van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn WB, Ebbels TMD, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia JL, Jimenez RC, Jourdan F, Kale N, Klapa MI, Kohlbacher O, Koort K, Kultima K, Le Corguillé G, Moreno P, Moschonas NK, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek RM, Sansone SA, Satagopam V, Schober D, Shimmo R, Spicer RA, Spjuth O, Thévenot EA, Viant MR, Weber RJM, Willighagen EL, Zanetti G, Steinbeck C.

Version 2. F1000Res. 2017 Sep 6 [revised 2017 Jan 1];6. pii: ELIXIR-1649. doi: 10.12688/f1000research.12342.2. eCollection 2017.

36.

Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.

Lanz HL, Saleh A, Kramer B, Cairns J, Ng CP, Yu J, Trietsch SJ, Hankemeier T, Joore J, Vulto P, Weinshilboum R, Wang L.

BMC Cancer. 2017 Nov 2;17(1):709. doi: 10.1186/s12885-017-3709-3.

37.

Blood-based metabolic signatures in Alzheimer's disease.

de Leeuw FA, Peeters CFW, Kester MI, Harms AC, Struys EA, Hankemeier T, van Vlijmen HWT, van der Lee SJ, van Duijn CM, Scheltens P, Demirkan A, van de Wiel MA, van der Flier WM, Teunissen CE.

Alzheimers Dement (Amst). 2017 Sep 6;8:196-207. doi: 10.1016/j.dadm.2017.07.006. eCollection 2017.

38.

Cellular glutathione levels in HL-60 cells during respiratory burst are not correlated with ultra-weak photon emission.

Burgos RCR, Zhang W, van Wijk EPA, Hankemeier T, Ramautar R, van der Greef J.

J Photochem Photobiol B. 2017 Oct;175:291-296. doi: 10.1016/j.jphotobiol.2017.09.002. Epub 2017 Sep 7.

39.

Multivariate pharmacokinetic/pharmacodynamic (PKPD) analysis with metabolomics shows multiple effects of remoxipride in rats.

van den Brink WJ, Elassaiss-Schaap J, Gonzalez-Amoros B, Harms AC, van der Graaf PH, Hankemeier T, de Lange ECM.

Eur J Pharm Sci. 2017 Nov 15;109:431-440. doi: 10.1016/j.ejps.2017.08.031. Epub 2017 Sep 4.

40.

A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes.

Liu J, van Klinken JB, Semiz S, van Dijk KW, Verhoeven A, Hankemeier T, Harms AC, Sijbrands E, Sheehan NA, van Duijn CM, Demirkan A.

Diabetes. 2017 Nov;66(11):2915-2926. doi: 10.2337/db17-0199. Epub 2017 Aug 28.

41.

Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes.

Trietsch SJ, Naumovska E, Kurek D, Setyawati MC, Vormann MK, Wilschut KJ, Lanz HL, Nicolas A, Ng CP, Joore J, Kustermann S, Roth A, Hankemeier T, Moisan A, Vulto P.

Nat Commun. 2017 Aug 15;8(1):262. doi: 10.1038/s41467-017-00259-3.

42.

Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study.

Liu J, Semiz S, van der Lee SJ, van der Spek A, Verhoeven A, van Klinken JB, Sijbrands E, Harms AC, Hankemeier T, van Dijk KW, van Duijn CM, Demirkan A.

Metabolomics. 2017;13(9):104. doi: 10.1007/s11306-017-1239-2. Epub 2017 Jul 28.

43.

Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men.

Kantae V, Nahon KJ, Straat ME, Bakker LEH, Harms AC, van der Stelt M, Hankemeier T, Jazet IM, Boon MR, Rensen PCN.

Sci Rep. 2017 Aug 8;7(1):7558. doi: 10.1038/s41598-017-07980-5.

44.

Fetal Metabolic Stress Disrupts Immune Homeostasis and Induces Proinflammatory Responses in Human Immunodeficiency Virus Type 1- and Combination Antiretroviral Therapy-Exposed Infants.

Schoeman JC, Moutloatse GP, Harms AC, Vreeken RJ, Scherpbier HJ, Van Leeuwen L, Kuijpers TW, Reinecke CJ, Berger R, Hankemeier T, Bunders MJ.

J Infect Dis. 2017 Aug 15;216(4):436-446. doi: 10.1093/infdis/jix291.

45.

Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.

van Esbroeck ACM, Janssen APA, Cognetta AB 3rd, Ogasawara D, Shpak G, van der Kroeg M, Kantae V, Baggelaar MP, de Vrij FMS, Deng H, Allarà M, Fezza F, Lin Z, van der Wel T, Soethoudt M, Mock ED, den Dulk H, Baak IL, Florea BI, Hendriks G, De Petrocellis L, Overkleeft HS, Hankemeier T, De Zeeuw CI, Di Marzo V, Maccarrone M, Cravatt BF, Kushner SA, van der Stelt M.

Science. 2017 Jun 9;356(6342):1084-1087. doi: 10.1126/science.aaf7497.

46.

Towards personalized treatment of pain using a quantitative systems pharmacology approach.

Goulooze SC, Krekels EHJ, van Dijk M, Tibboel D, van der Graaf PH, Hankemeier T, Knibbe CAJ, van Hasselt JGC.

Eur J Pharm Sci. 2017 Nov 15;109S:S32-S38. doi: 10.1016/j.ejps.2017.05.027. Epub 2017 May 12. Review.

47.

Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.

Kohler I, Hankemeier T, van der Graaf PH, Knibbe CAJ, van Hasselt JGC.

Eur J Pharm Sci. 2017 Nov 15;109S:S15-S21. doi: 10.1016/j.ejps.2017.05.018. Epub 2017 May 11. Review.

48.

Ultra-weak photon emission as a dynamic tool for monitoring oxidative stress metabolism.

Burgos RCR, Schoeman JC, Winden LJV, Červinková K, Ramautar R, Van Wijk EPA, Cifra M, Berger R, Hankemeier T, Greef JV.

Sci Rep. 2017 Apr 27;7(1):1229. doi: 10.1038/s41598-017-01229-x.

49.

Metabolic network failures in Alzheimer's disease: A biochemical road map.

Toledo JB, Arnold M, Kastenmüller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, Risacher SL, Blach C, Lucas JE, Massaro T, Louie G, Zhu H, Dallmann G, Klavins K, Koal T, Kim S, Nho K, Shen L, Casanova R, Varma S, Legido-Quigley C, Moseley MA, Zhu K, Henrion MYR, van der Lee SJ, Harms AC, Demirkan A, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Saykin AJ, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2017 Sep;13(9):965-984. doi: 10.1016/j.jalz.2017.01.020. Epub 2017 Mar 22.

50.

Role of amino acids in rheumatoid arthritis studied by metabolomics.

He M, Harms AC, van Wijk E, Wang M, Berger R, Koval S, Hankemeier T, van der Greef J.

Int J Rheum Dis. 2019 Jan;22(1):38-46. doi: 10.1111/1756-185X.13062. Epub 2017 Mar 22.

PMID:
28328075

Supplemental Content

Loading ...
Support Center